• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病。

Kawasaki disease.

机构信息

Japan Kawasaki Disease Research Center, Tokyo, Japan.

出版信息

Proc Jpn Acad Ser B Phys Biol Sci. 2006 Apr;82(2):59-71. doi: 10.2183/pjab.82.59.

DOI:10.2183/pjab.82.59
PMID:25792773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4323050/
Abstract

Short history of Kawasaki disease, clinical features (principal symptoms and other significant symptoms or findings), diagnosis, cardiovascular involvement, epidemiology. Pathological features (lesion of vessels and lesion of organs exclusive of vessels), comparison between infantile periarteritis nodosa (IPN)/Kawasaki disease and classic periarteritis nodosa (CPN), etiology, treatment and management of Kawasaki disease are described.

摘要

川崎病简史、临床特征(主要症状和其他显著症状或发现)、诊断、心血管并发症、流行病学。病理特征(血管病变和血管外器官病变)、婴儿结节性多动脉炎(IPN)/川崎病与经典结节性多动脉炎(CPN)的比较、病因、川崎病的治疗和管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e31/4323050/3e92b2072e39/82_59f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e31/4323050/a88bea253a63/82_59f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e31/4323050/e222af07beeb/82_59f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e31/4323050/2d17a6d94255/82_59f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e31/4323050/b9a612bd2c0f/82_59f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e31/4323050/3e92b2072e39/82_59f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e31/4323050/a88bea253a63/82_59f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e31/4323050/e222af07beeb/82_59f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e31/4323050/2d17a6d94255/82_59f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e31/4323050/b9a612bd2c0f/82_59f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e31/4323050/3e92b2072e39/82_59f5.jpg

相似文献

1
Kawasaki disease.川崎病。
Proc Jpn Acad Ser B Phys Biol Sci. 2006 Apr;82(2):59-71. doi: 10.2183/pjab.82.59.
2
Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lymph node syndrome the same? Comparison of 20 patients from North America with patients from Hawaii and Japan.伴有冠状动脉受累的婴儿结节性多动脉炎与致死性皮肤黏膜淋巴结综合征相同吗?北美20例患者与夏威夷及日本患者的比较。
Pediatrics. 1977 May;59(5):651-62.
3
Kawasaki disease. Relationship with infantile periarteritis nodosa.川崎病。与婴儿结节性多动脉炎的关系。
Arch Pathol Lab Med. 1976 Feb;100(2):81-6.
4
Infantile periarteritis nodosa or mucocutaneous lymph node syndrome. A report on four cases and diagnostic considerations.婴儿结节性多动脉炎或皮肤黏膜淋巴结综合征。四例报告及诊断思考。
Acta Paediatr Scand. 1977 Mar;66(2):193-8. doi: 10.1111/j.1651-2227.1977.tb07832.x.
5
Kawasaki disease. Mucocutaneous lymph node syndrome or MCLS.川崎病。黏膜皮肤淋巴结综合征或MCLS。
Acta Pathol Jpn. 1982;32 Suppl 1:63-72.
6
Kawasaki disease: A brief history.川崎病:简史
Pediatrics. 2000 Aug;106(2):E27. doi: 10.1542/peds.106.2.e27.
7
Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome).川崎病(皮肤黏膜淋巴结综合征)的病理特征。
Am J Cardiovasc Pathol. 1987;1(2):218-29.
8
[Kawasaki syndrome. Apropos of a case].[川崎病。关于一例病例]
Sem Hop. 1984 Feb 16;60(8):583-7.
9
[The mucocutaneous and lymph node syndrome of Kawasaki. 1 case complicated by multiple aneurysms].[川崎病的黏膜皮肤淋巴结综合征。1例并发多发性动脉瘤]
Sem Hop. 1978 Apr;54(9-12):442-7.
10
[Kawasaki syndrome--a new disease?].[川崎病——一种新疾病?]
Klin Padiatr. 1980 May;192(3):173-8. doi: 10.1055/s-2008-1035579.

引用本文的文献

1
Molecular characterization of Kawasaki disease subgroups using cell-free RNA profiling.利用无细胞RNA分析对川崎病亚组进行分子特征分析。
Sci Rep. 2025 Aug 14;15(1):29799. doi: 10.1038/s41598-025-15843-7.
2
Concurrent infections in children with Kawasaki disease: lessons learned over 26 years.川崎病患儿的并发感染:26年经验教训
Immunol Res. 2025 Feb 26;73(1):56. doi: 10.1007/s12026-025-09607-8.
3
Dysbiosis of the gut microbiota as a susceptibility factor for Kawasaki disease.肠道微生物失调作为川崎病易感性因素。

本文引用的文献

1
Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.川崎病外周血淋巴细胞及单核细胞/巨噬细胞的免疫特征
Clin Exp Immunol. 2005 Sep;141(3):381-7. doi: 10.1111/j.1365-2249.2005.02821.x.
2
Infliximab treatment for refractory Kawasaki syndrome.英夫利昔单抗治疗难治性川崎综合征。
J Pediatr. 2005 May;146(5):662-7. doi: 10.1016/j.jpeds.2004.12.022.
3
Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody.利用合成抗体检测急性川崎病支气管上皮和巨噬细胞中的抗原。
Front Immunol. 2023 Oct 31;14:1268453. doi: 10.3389/fimmu.2023.1268453. eCollection 2023.
4
Comparison of Characteristics and Outcomes of Multisystem Inflammatory Syndrome, Kawasaki Disease and Toxic Shock Syndrome in Children.比较儿童多系统炎症综合征、川崎病和中毒性休克综合征的特征和结局。
Medicina (Kaunas). 2023 Mar 21;59(3):626. doi: 10.3390/medicina59030626.
5
COVID-19 disease and autoimmune disorders: A mutual pathway.2019冠状病毒病与自身免疫性疾病:一条共同途径。
World J Methodol. 2022 Jul 20;12(4):200-223. doi: 10.5662/wjm.v12.i4.200.
6
The Multifaceted Manifestations of Multisystem Inflammatory Syndrome during the SARS-CoV-2 Pandemic.新冠疫情期间多系统炎症综合征的多方面表现
Pathogens. 2022 May 8;11(5):556. doi: 10.3390/pathogens11050556.
7
Incomplete Kawasaki Disease in an Infant: A Case Report and Literature Review.婴儿不完全川崎病:一例报告及文献综述
Cureus. 2022 Feb 11;14(2):e22122. doi: 10.7759/cureus.22122. eCollection 2022 Feb.
8
Kawasaki Disease With Combined Cholestatic Hepatitis and Infection: A Case Report and Literature Review.川崎病合并胆汁淤积性肝炎及感染:病例报告与文献综述
Front Pediatr. 2022 Feb 9;9:738215. doi: 10.3389/fped.2021.738215. eCollection 2021.
9
Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome.川崎病与川崎病样综合征的细胞因子级联反应。
Physiol Res. 2022 Mar 25;71(1):17-27. doi: 10.33549/physiolres.934672. Epub 2022 Jan 19.
10
Distinguishing Between Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children and the Kawasaki Disease: Development of Preliminary Criteria Based on the Data of the Retrospective Multicenter Cohort Study.儿童新冠病毒相关多系统炎症综合征与川崎病的鉴别:基于回顾性多中心队列研究数据制定初步标准
Front Pediatr. 2021 Nov 10;9:787353. doi: 10.3389/fped.2021.787353. eCollection 2021.
J Infect Dis. 2004 Aug 15;190(4):856-65. doi: 10.1086/422648. Epub 2004 Jul 16.
4
Commentary: translation of Dr. Tomisaku Kawasaki's original report of fifty patients in 1967.评论:川崎富作医生1967年关于50例患者的原始报告译文
Pediatr Infect Dis J. 2002 Nov;21(11):993-5. doi: 10.1097/00006454-200211000-00002.
5
Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease: quantitative coronary artery angiography and intravascular ultrasound imaging study.川崎病后冠状动脉病变导管介入治疗的序贯随访结果:定量冠状动脉造影和血管内超声成像研究
Circulation. 2002 Jun 25;105(25):3004-10. doi: 10.1161/01.cir.0000019733.56553.d8.
6
Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.免疫球蛋白抵抗型川崎病的再治疗:额外免疫球蛋白与类固醇脉冲疗法的比较研究
Pediatr Int. 2001 Jun;43(3):211-7. doi: 10.1046/j.1442-200x.2001.01373.x.
7
Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease.川崎病患者中携带TCRBV2和TCRBV6的T细胞的多克隆扩增。
Immunology. 1999 Mar;96(3):465-72. doi: 10.1046/j.1365-2567.1999.00695.x.
8
Intravascular ultrasound of coronary arteries in children. Assessment of the wall morphology and the lumen after Kawasaki disease.儿童冠状动脉血管内超声检查。川崎病后血管壁形态及管腔评估。
Circulation. 1994 Jan;89(1):258-65. doi: 10.1161/01.cir.89.1.258.
9
Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study.川崎病冠状动脉疾病患者心肌血运重建的长期预后。一项多中心合作研究。
J Thorac Cardiovasc Surg. 1994 Mar;107(3):663-73; discussion 673-4.
10
Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study.川崎病冠状动脉瘤的转归:系列冠状动脉造影及长期随访研究
Am J Cardiol. 1982 May;49(7):1758-66. doi: 10.1016/0002-9149(82)90256-9.